• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环糊精作为多功能辅料:将 Tebipenem pivoxil 包合于β-环糊精对其理化性质和生物学性质的影响。

Cyclodextrins as multifunctional excipients: Influence of inclusion into β-cyclodextrin on physicochemical and biological properties of tebipenem pivoxil.

机构信息

Department of Pharmacognosy, Poznan University of Medical Sciences, Święcickiego, Poznan, Poland.

Department of Biotechnology and Food Microbiology, Poznan University of Life Sciences, Wojska Polskiego, Poznan, Poland.

出版信息

PLoS One. 2019 Jan 25;14(1):e0210694. doi: 10.1371/journal.pone.0210694. eCollection 2019.

DOI:10.1371/journal.pone.0210694
PMID:30682086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6347292/
Abstract

A novel approach for drug design based on the oral carbapenem analog tebipenem pivoxil (TP) has been proposed. The formation of the tebipenem pivoxil-β-cyclodextrin (TP-β-CD) complex resulted in changes concerning physicochemical properties of TP, which is significant for planning the development of an innovative pharmaceutical formulation as well as in the modifications of biological activity profile of the studied delivery system. The inclusion of TP into β-cyclodextrin (β-CD) was confirmed by spectral (infrared and Raman spectroscopies) and thermal method (differential scanning calorimetry). Precise indications of TP domains responsible for interaction with β-CD were possible through a theoretical approach. The most important physicochemical modifications obtained as an effect of TP inclusion were changes in solubility and its rate depending on acceptor fluids, and an increase in chemical stability in the solid state. Biologically essential effects of TP and β-CD interactions were decreased TP permeability through Caco-2 cell monolayers with the use of efflux effect inhibition and increased antibacterial activity. The proposed approach is an opportunity for development of the treatment in resistant bacterial infections, in which along with physicochemical modifications induced by a drug carrier impact, a carrier synergy with a pharmacological potential of an active pharmaceutical substance could be used.

摘要

基于口服碳青霉烯类似物替比培南匹伏酯(TP)的药物设计提出了一种新方法。替比培南匹伏酯-β-环糊精(TP-β-CD)复合物的形成导致了 TP 的物理化学性质的变化,这对于规划创新药物制剂的开发以及研究给药系统的生物活性特征的改变具有重要意义。通过光谱(红外和拉曼光谱)和热法(差示扫描量热法)证实了 TP 纳入 β-环糊精(β-CD)。通过理论方法可以确定与 β-CD 相互作用的 TP 结构域的精确指示。作为 TP 纳入的结果,获得的最重要的物理化学修饰是溶解度及其随接受流体的变化,以及在固态下化学稳定性的提高。TP 和 β-CD 相互作用的生物学重要影响是通过抑制外排效应和提高抗菌活性来降低通过 Caco-2 细胞单层的 TP 渗透性。该方法为治疗耐药细菌感染提供了机会,其中除了药物载体影响引起的物理化学修饰外,载体与活性药物物质的药理潜力的协同作用也可以得到利用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1a/6347292/b617ea6fbd06/pone.0210694.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1a/6347292/6930e020819e/pone.0210694.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1a/6347292/ffac13de1c2b/pone.0210694.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1a/6347292/e6b75cb0dfae/pone.0210694.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1a/6347292/f45a3fd17271/pone.0210694.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1a/6347292/36c0c0f094d5/pone.0210694.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1a/6347292/604539ba69f5/pone.0210694.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1a/6347292/904be78b3aa6/pone.0210694.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1a/6347292/aef1616288e3/pone.0210694.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1a/6347292/b617ea6fbd06/pone.0210694.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1a/6347292/6930e020819e/pone.0210694.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1a/6347292/ffac13de1c2b/pone.0210694.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1a/6347292/e6b75cb0dfae/pone.0210694.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1a/6347292/f45a3fd17271/pone.0210694.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1a/6347292/36c0c0f094d5/pone.0210694.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1a/6347292/604539ba69f5/pone.0210694.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1a/6347292/904be78b3aa6/pone.0210694.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1a/6347292/aef1616288e3/pone.0210694.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b1a/6347292/b617ea6fbd06/pone.0210694.g009.jpg

相似文献

1
Cyclodextrins as multifunctional excipients: Influence of inclusion into β-cyclodextrin on physicochemical and biological properties of tebipenem pivoxil.环糊精作为多功能辅料:将 Tebipenem pivoxil 包合于β-环糊精对其理化性质和生物学性质的影响。
PLoS One. 2019 Jan 25;14(1):e0210694. doi: 10.1371/journal.pone.0210694. eCollection 2019.
2
Tedizolid-Cyclodextrin System as Delayed-Release Drug Delivery with Antibacterial Activity.替考拉宁-环糊精系统作为具有抗菌活性的迟释药物递送系统。
Int J Mol Sci. 2020 Dec 24;22(1):115. doi: 10.3390/ijms22010115.
3
Physico-chemical characterization and antibacterial activity of inclusion complexes of Hyptis martiusii Benth essential oil in β-cyclodextrin.Hyptis martiusii Benth 精油-β-环糊精包合物的理化性质表征及抑菌活性
Biomed Pharmacother. 2017 May;89:201-207. doi: 10.1016/j.biopha.2017.01.158. Epub 2017 Feb 20.
4
Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.他达拉非与天然及化学修饰的β-环糊精的包合物。I:制备及体外评价
Eur J Pharm Biopharm. 2008 Nov;70(3):819-27. doi: 10.1016/j.ejpb.2008.06.024. Epub 2008 Jul 4.
5
Enhanced pharmacological efficacy of sumatriptan due to modification of its physicochemical properties by inclusion in selected cyclodextrins.通过将舒马曲坦包合于选定的环糊精中,改变其物理化学性质,从而增强其药效。
Sci Rep. 2018 Nov 1;8(1):16184. doi: 10.1038/s41598-018-34554-w.
6
Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin.羟丙基-β-环糊精对头孢地尼的增溶作用。
Drug Dev Ind Pharm. 2013 Nov;39(11):1638-43. doi: 10.3109/03639045.2012.728231.
7
Inclusion complexes of hydrochlorothiazide and β-cyclodextrin: Physicochemical characteristics, in vitro and in vivo studies.氢氯噻嗪与β-环糊精的包合物:物理化学特性、体外和体内研究
Eur J Pharm Sci. 2016 Feb 15;83:71-8. doi: 10.1016/j.ejps.2015.12.015. Epub 2015 Dec 11.
8
Improvement on dissolution rate of inclusion complex of Rifabutin drug with β-cyclodextrin.提高利福布丁药物与β-环糊精包合物的溶解速率。
Int J Biol Macromol. 2013 Nov;62:472-80. doi: 10.1016/j.ijbiomac.2013.09.006. Epub 2013 Sep 25.
9
Formation of β-cyclodextrin inclusion enhances the stability and aqueous solubility of natural borneol.β-环糊精包合物的形成增强了天然龙脑的稳定性和水溶性。
J Food Sci. 2012 Jun;77(6):C658-64. doi: 10.1111/j.1750-3841.2012.02713.x. Epub 2012 May 14.
10
Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.盐酸布比卡因环糊精包合物的制备及其口腔给药的固态特性研究。
J Pharm Biomed Anal. 2010 May 1;52(1):9-18. doi: 10.1016/j.jpba.2009.11.013. Epub 2009 Nov 18.

引用本文的文献

1
Comparative Investigation into the Roles of Imipenem:Cyclodextrin Complexation and Antibiotic Combination in Combatting Antimicrobial Resistance in Gram-Negative Bacteria.亚胺培南与环糊精络合及抗生素联合在对抗革兰氏阴性菌耐药性中的作用比较研究
Pharmaceuticals (Basel). 2023 Oct 23;16(10):1508. doi: 10.3390/ph16101508.
2
Cyclodextrin: A prospective nanocarrier for the delivery of antibacterial agents against bacteria that are resistant to antibiotics.环糊精:一种用于递送针对抗生素耐药细菌的抗菌剂的潜在纳米载体。
Heliyon. 2023 Aug 24;9(9):e19287. doi: 10.1016/j.heliyon.2023.e19287. eCollection 2023 Sep.
3

本文引用的文献

1
: an error-correcting CIF parser for the Perl language.用于Perl语言的纠错CIF解析器。
J Appl Crystallogr. 2016 Feb 1;49(Pt 1):292-301. doi: 10.1107/S1600576715022396.
2
Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.替比培南匹伐酯片(一种新型口服碳青霉烯制剂)对多种病原菌的体内外抗菌特性
Molecules. 2016 Jan 6;21(1):62. doi: 10.3390/molecules21010062.
3
β-Cyclodextrin complexation as an effective drug delivery system for meropenem.
Recent Advances in the Pharmaceutical and Biomedical Applications of Cyclodextrin-Capped Gold Nanoparticles.
环糊精包覆金纳米粒子在药物和生物医学应用中的最新进展。
Int J Nanomedicine. 2023 Jun 14;18:3247-3281. doi: 10.2147/IJN.S405964. eCollection 2023.
4
Weak complexation of 5-fluorouracil with β-cyclodextrin, carbonate, and dianhydride crosslinked β-cyclodextrin: and studies.5-氟尿嘧啶与β-环糊精、碳酸盐及二酐交联β-环糊精的弱络合作用及研究
Res Pharm Sci. 2022 Jul 14;17(4):334-349. doi: 10.4103/1735-5362.350235. eCollection 2022 Aug.
5
Cyclodextrin Inclusion Complexes with Antibiotics and Antibacterial Agents as Drug-Delivery Systems-A Pharmaceutical Perspective.环糊精与抗生素及抗菌剂形成的包合物作为药物递送系统——药学视角
Pharmaceutics. 2022 Jun 30;14(7):1389. doi: 10.3390/pharmaceutics14071389.
6
Molecular Structure of Cefuroxime Axetil Complexes with α-, β-, γ-, and 2-Hydroxypropyl-β-Cyclodextrins: Molecular Simulations and Raman Spectroscopic and Imaging Studies.头孢呋辛酯与α-、β-、γ-和2-羟丙基-β-环糊精配合物的分子结构:分子模拟、拉曼光谱和成像研究
Int J Mol Sci. 2021 May 15;22(10):5238. doi: 10.3390/ijms22105238.
7
Tedizolid-Cyclodextrin System as Delayed-Release Drug Delivery with Antibacterial Activity.替考拉宁-环糊精系统作为具有抗菌活性的迟释药物递送系统。
Int J Mol Sci. 2020 Dec 24;22(1):115. doi: 10.3390/ijms22010115.
8
Hydroxypropyl-β-cyclodextrin as an effective carrier of curcumin - piperine nutraceutical system with improved enzyme inhibition properties.羟丙基-β-环糊精作为姜黄素-胡椒碱营养保健品系统的有效载体,具有改善的酶抑制特性。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1811-1821. doi: 10.1080/14756366.2020.1801670.
9
Computer-Aided Design of Cefuroxime Axetil/Cyclodextrin System with Enhanced Solubility and Antimicrobial Activity.计算机辅助设计头孢呋辛酯/环糊精系统具有增强的溶解性和抗菌活性。
Biomolecules. 2019 Dec 23;10(1):24. doi: 10.3390/biom10010024.
10
Machine Learning Approach for Determining the Formation of β-Lactam Antibiotic Complexes with Cyclodextrins Using Multispectral Analysis.利用多光谱分析测定β-内酰胺抗生素与环糊精形成复合物的机器学习方法。
Molecules. 2019 Feb 19;24(4):743. doi: 10.3390/molecules24040743.
β-环糊精包合作为美罗培南的一种有效药物递送系统。
Eur J Pharm Biopharm. 2016 Feb;99:24-34. doi: 10.1016/j.ejpb.2015.10.013. Epub 2015 Nov 22.
4
Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections.碳青霉烯类耐药肠杆菌科感染的治疗选择。
Open Forum Infect Dis. 2015 May 5;2(2):ofv050. doi: 10.1093/ofid/ofv050. eCollection 2015 Apr.
5
Solid-state stability studies of crystal form of tebipenem.替比培南晶型的固态稳定性研究
Drug Dev Ind Pharm. 2016;42(2):238-44. doi: 10.3109/03639045.2015.1044902. Epub 2015 Jun 5.
6
Prediction of HPLC retention times of tebipenem pivoxyl and its degradation products in solid state by applying adaptive artificial neural network with recursive features elimination.应用具有递归特征消除功能的自适应人工神经网络预测替比培南酯及其降解产物在固态下的高效液相色谱保留时间。
Talanta. 2015 May;137:174-81. doi: 10.1016/j.talanta.2015.01.032. Epub 2015 Feb 4.
7
Overexpression of an outer membrane protein associated with decreased susceptibility to carbapenems in Proteus mirabilis.奇异变形杆菌中一种与对碳青霉烯类药物敏感性降低相关的外膜蛋白的过表达。
PLoS One. 2015 Mar 10;10(3):e0120395. doi: 10.1371/journal.pone.0120395. eCollection 2015.
8
The chromatographic approach to kinetic studies of tebipenem pivoxil.替比培南酯动力学研究的色谱方法
J Chromatogr Sci. 2015 Feb;53(2):325-30. doi: 10.1093/chromsci/bmu063. Epub 2014 Jun 30.
9
Modified β-cyclodextrin inclusion complex to improve the physicochemical properties of albendazole. complete in vitro evaluation and characterization.改性β-环糊精包合物改善阿苯达唑的理化性质。完整的体外评价与表征。
PLoS One. 2014 Feb 14;9(2):e88234. doi: 10.1371/journal.pone.0088234. eCollection 2014.
10
Cyclodextrin derivatives as anti-infectives.环糊精衍生物作为抗感染剂。
Curr Opin Pharmacol. 2013 Oct;13(5):717-25. doi: 10.1016/j.coph.2013.08.007. Epub 2013 Sep 4.